Upload
debby-tamara
View
82
Download
13
Embed Size (px)
Citation preview
Case Report
A 51 Years Old Female Came to The Hospital with Chief
Complaint The Enlargement of Abdominal Bulging
became Worse since One Day before Admission.
By :
Much. Apriyanto, S.Ked (04061001008)Khori Pretika, S.Ked (04061001111)
Advisor :Prof. Dr. H. Eddy Mart Salim, SpPD, K-AI, FINASIM
Internal Medicine Department
Medical Faculty of Sriwijaya University
2010
0
CHAPTER I
INTRODUCTION
Tuberculosis (TB) is still become one of the leading health problem in the world.
Based in the data in 1955, Approximately there 9 million people infected Tuberculosis and
3 million of those case are end with death. Beside that the cause of death among women
with Tb are greater than the death with delivery. It is expected that the number of people
affected by cirrhosis will continue to increase in the near future. Beause of that, since 1993
WHO announce TB as a global emergency
Indonesia still in the 3rd rank for the number of TB patient and it is 10% from all TB
patient all over the world. it is expected that start from 2004 there will be 539.000 new
case of TB appear in every years with the number of death for about 101.000 people.
Tuberculosis is refer to a contagious disease that caused by Mycobacterium
Tuberculosis bacteria, it oftenly effect lungs, but in come case there are also infection
outside the lungs.
Tuberculosis is a chronic disease that can increase morbidity and mortality if not
managed professionally. Accurate diagnosis and appropriate treatment are needed for
physician to the treatment of Tuberculosis. Therefore we raised the Tuberculosis for our
case to understand about this disease, so that it can help improve the quality of life of
patients with liver Tuberculosis.
1
CHAPTER II
CASE REPORT
II.1 IDENTIFICATION
Name : Mrs. MN
Age : 66 years old
Sex : Female
Address : ogan ilir
Status : Married
Occupation : Mother Household
Religion : Muslim
Hospitalized : September, 14th 2010 (15.00 p.m)
Med Rec No :
II.2 ANAMNESIS
Chief complaint :
Cough that became worse since one day before admission.
History of illness :
Since 3 month before admission, Mrs.Mn started to get cough, in every cough there
was a half of pleghm that colorless and with no blood streak. There was complaint neither
shortness of breath nor chest pain. She also felt fever, with no shaking and sweating in
night time. There were no nausea and vomit. Since her sickness, Mrs. Mn felt that se
oftened lost her appetite but still no body weight loss. The defecation and urination just
like usual.
Since 1 week before admission, Mrs.Mn started to get cough, in every cough there
was a half of pleghm that colorless and with no blood streak. Sometimes there were
shortness of breath while the weather is too hot. Mrs. Mn went to the midwife, then she got
3 kinds of drugs, an expectorant, vitamin and one another drug that she didnt recognize.
After eat drugs the symptom didnt relieve at all.
2
About one day before admission in RSMH, Mrs.Mn felt her cough became
worse, the frequency and the amount of pleghm are increased. Beside that the
colour of pleghm has turned yellow. There are still no shortness of breath, chest
pain, nausea and vomit. Her body weigh has decreased. Then, she came again to
the midwife, and got suggestion to go to RSMH.
History of previous illness :
No history of taking drugs for 6 months or taking drugs that make her urine turn red.
There is a history of living among people that oftenly get cough for a long period.
No history of hypertension.
No history of diabetes.
Familiy history :
There is no family member that has the same symptom like her.
History of Habitual.
She never smoke
II.3 PHISYCAL EXAMINATION (September,14th 2010)
General Condition
Sickness condition : moderately sick
Consciousness : compos mentis
Blood Pressure : 100/60 mmHg
Pulse rate : 88 times/minute
Respiration rate : 28 times/minute
Temperature : 36,80 C
Weight : 25 kg
Height : 150 cm
3
Specific Condition
• Skin
The color of the skin is black-brown, cyanosis (-), pale on palm of hands (+), pale on
sole of feet (-), normal hair growth, skin turgor (+) and dry skin (+)
• Lymph nodes
There are no enlargment of the lymph nodes on submandibular, neck, axilaries, and
inguinal.
• Head
Oval, symmetrical, alopecia (-), puffy face (-), deformity (-), malar rash (-).
• Eyes
Exopthalmus (-), endopthalmus (-), edematous of superior palpebrae (-), pale of
conjungtiva palpebrae (-/-), icteric sclera (-/-), pupils were isokor, Good light response
on both of eyes, symmetrical eyes movements.
• Nose
Normal outside appearance, no epitaksis, no obstruction.
• Ear
decreasing hearing ability (-).
• Mouth
Enlagrement of tonsils (-), no papil’s atrophy, stomatitis (-), rhagaden (-), specific
breath’s smell (-).
• Neck
Jugular venous pressure (5-2) cmH2O, lymph nodes enlargment (-), thyroid gland
enlargement (-), hypertrophy sternocleidomastoideus (-), stiffness (-).
• Thorax : Normal shape, spider naevi (-), pressure pain (-), crepitation (-)
• Cor
Inspection : Ictus cordis was not seen.
Palpation : Ictus cordis was not palpable.
Percussion : Upper heart margin at 2nd intercostal space, right margin at linea
parasternalis, left margin at LMC sinistra.
Auscultation : HR 88x/menit, murmur (-), gallop (-)
• Pulmo Anterior
4
Inspection : Static: both hemithoraxs were symmetric.
dynamic: same movement, no retraction.
Palpation : Stem fremitus in both hemithoraxs were equal deceased.
Percussion : Sonorous in both of lungs, border of pulmo-liver at ICS V.
Auscultation : Vesicular (+) normal in both of lungs, middle wet ronchi (+) at apical
and medial areas of lungs, wheezing (-).
• Pulmo Posterior :
Inspection : Static: both hemithoraxs were symmetric.
dynamic: same movement, no retraction.
Palpation : Stemfremitus in both hemithoraxs were equal decreased
Percussion : Sonorous in both of lungs,.
Auscultation : Vesicular (+) normal in both of lungs, middle wet ronchi (+) at apical
and medial areas of lungs wheezing (-).
• Abdomen
Inspection : flat.
Palpation : supple, pressure pain(-), liver and spleen didn’t palpable.
Percussion : Percussion pain (-), shifting dullness (-), undulation (-)
Auscultation : Normal bowel sound
• Genital : Had not been examined
• Extremities :
• Upper extremity
Paint on joint (-), pale on finger (-), erythema of palm (-), pitting edema (-/-).
• Lower extremity
Pain on joint (-), varices (-), pale on sole of foot (-), pretibial edema (-/-)
II.4. SUPPORTIVE EXAMINATION
5
Laboratory Finding
Result Normal value
Hb : 11,1 g/dl
Leukosit : 13.000
Trombosit : 270.000
LED : 62
Ht : 37%
DC :0/0/1/84/8/7
GDS : 180 mg/dl
SGOT : 39
SGPT : 16
Protein total : 6,3
Albumin : 2,1
Globulin : 4,2
Ureum : 58
Kreatinin : 1,0
Kolesterol : 120
HDL Kolesterol : 58
LDL Kolesterol : 49
Trygliserida : 67
Natrium : 131
Kalium : 4,7
P = 12 – 14 g/dl
5000 – 10000/uI
150.000 – 400.000/uI
< 20 mm/jam
33 – 43%
0-1/1-3/2-6/50-70/20-40/2-8
< 200 mg/dl
< 40 U/I
< 41 U/I
6,0 – 7,8 g/dl
3,8 – 5,1g/dl
1,5 – 3 g/dl
15 – 39 mg/dl
0,9 – 1,3 mg/dl
< 200 mg/dl
> 65 mg/dl
< 130 mg/dl
< 150 mg/dl
135 – 155 mmol/l
3,5 – 5,5 mmol/l
Rontgen Thorax PA
- infiltrat pada upper and middle area of lungs ( lung tuberculosis with large lesion)
Ele c tro c ardiogra phy
Sinus rhytm, Right Axis, HR: 90x/m, P peak wave, PR interval 0,12 sc, komplex QRS
0,06 sc, R/S V1> 1, SV1 + RV5V6 < 35 mm, T inverted at II, III, aVF, V1, V6.
assasment : RVH + P. pulmonal+ iskemik ekstensive anterior
BTA Examination ( September , 20 th 2010 )
6
BTA I : Negatif
BTA II : Negatif
BTA III : Negatif
II.4 RESUME
A 66 years old women admitted to hospital on September 14th, 2010 with chief
complaint worse since one day before admission since one day before admission. 3 month
before admission, Mrs.Mn started to get cough, in every cough there was a half of pleghm
that colorless and with no blood streak. There was complaint neither shortness of breath
nor chest pain. She also felt fever, with no shaking and sweating in night time. There were
no nausea and vomit. Since her sickness, Mrs. Mn felt that se oftened lost her appetite but
still no body weight loss. The defecation and urination just like usual. one week before
admission, Mrs.Mn started to get cough, in every cough there was a half of pleghm that
colorless and with no blood streak. Sometimes there were shortness of breath while the
weather is too hot. Mrs. Mn went to the midwife, then she got 3 kinds of drugs, an
expectorant, vitamin and one another drug that she didnt recognize. After eat drugs the
symptom didnt relieve at all. one day before admission in RSMH, Mrs.Mn felt her cough
became worse, the frequency and the amount of pleghm are increased. Beside that the
colour of pleghm has turned yellow. There are still no shortness of breath, chest pain,
nausea and vomit. Her body weigh has decreased. Then, she came again to the midwife,
and got suggestion to go to RSMH.
From physical examination we found: There are a d decreased of skin turgor and
dry skin. Palpation Stem fremitus in both hemithoraxs were equal deceased. Auscultation
Vesicular normal in both of lungs, middle wet ronchi at apical and medial areas of lungs.
From laboratorium examination we found : Hb 11,1 g/dl, Leukosit 13.000/uI, DC
(0/0/1/84/8/7), LED 62 mm/Hours, Albumin 2,1 gram/dl, Natrium 131mmol/l, Ureum 58
mg/dl.
Rontgen photo shows infiltration on upper and middle area of lungs ( lung
tuberculosis with large lesion). Electrocardiograph shows RVH , P. pulmonal wave and
ischemic extensive anterior .From BTA Examination we got BTA I, II, and III are all in
Negatif value.
7
II.6 WORKING DIAGNOSIS
New case findings of tuberculosa with negative BTA and Positive radiologist and
malnutrition.
II.7 DIFFERENTIAL DIAGNOSIS
Upper respiratory tract infection with malnutrition.
II.8 TREATMENT
Non-pharmacology:
• Bed rest
• Diet high calories and protein
Pharmacology:
• IVFD RL : D5% = 2:1 gtt xx/m (micro)
• Ceftriaxone
• Ambroxol 3x1 CI
• Albumin 500 cc/hari
• Vitamin B1, B6, B12
• Planning for OAT
• INH 1 x 150 mg
• Rifampisin 1 x 450 mg
• Pirazinamid 1 x 1000 mg
• Ethambutol 1 x 500 mg
II.9 PLANNING EXAMINATION
Lab examination / 24 hours to monitor improvement of Natrium, Kalium, Albumin.
Electrocardiography
Lung function test
Alergic test
BTA I, II, III
8
II.9 PROGNOSIS
Quo ad vitam : dubia ad bonam
Quo ad functionam : dubia ad bonam
FOLLOW UP
September , 28th 2010
S Abdominal pain
O
General condition• Conciousness : compos mentis• Blood preassure : 90/70 mmHg• Pulse rate : 70x/minute• Respiration rate : 22x/minute• Temperature : 36,2ºC• Body weight : 25 kg
Spesific conditionPale of conjunctiva palpebra (-/-), icteric sclera (-/-), Jugular venous pressure (5-2) cmH2OThorax : Cor: HR 78 x/menit, murmur (-), gallop (-)Pulmo: Stem fremitus in both hemithoraxs were equal deceased Vesicular (+) normal in both of lungs, middle wet ronchi (+) at apical area of lungs, wheezing (-).
Abdomen Inspection : flat, Palpation : supple, borderline of pulmo-liver at ICS V, pressure pain (-), liver
and spleen didn’t palpablePercussion : shifting dulness (-)Auscultation : normal bowel sound
Extremities : pretibial edema -/-A New case findings of tuberculosa with negative BTA and Positive radiologist and
9
malnutrition.
P
IVFD RL : D5% = 2:1 gtt xx/m (micro) Ceftriaxone Ambroxol 3x1 CI Albumin 500 cc/day Vitamin B1, B6, B12 Planning for OAT INH 1 x 150 mg Rifampisin 1 x 450 mg Pirazinamid 1 x 1000 mg Ethambutol 1 x 500 mg
September 29th 2010S (-)
O
General condition• Conciousness : compos mentis• Blood preassure : 100/70 mmHg• Pulse rate : 75x/minute• Respiration rate : 22x/minute• Temperature : 36,3ºC• Body weight : 25 kg
Spesific conditionPale of conjunctiva palpebra (-/-), icteric sclera (-/-), Jugular venous pressure (5-2) cmH2OThorax :Cor: HR 75 x/menit, murmur (-), gallop (-)Pulmo: Stem fremitus in both hemithoraxs were equal deceased Vesicular (+) normal in both of lungs, middle wet ronchi (+) at apical areas of lungs, wheezing (-).
Abdomen Inspection : flat, Palpation : supple, borderline of pulmo-liver at ICS V, pressure pain (-), liver and spleen didn’t palpablePercussion : shifting dulness (-)Auscultation : normal bowel sound
Extremities : pretibial edema -/-A New case findings of tuberculosa with negative BTA and Positive radiologist and
10
malnutrition.
P
IVFD RL : D5% = 2:1 gtt xx/m (micro) Ceftriaxone Ambroxol 3x1 CI Albumin 500 cc/day Vitamin B1, B6, B12 Planning for OAT INH 1 x 150 mg Rifampisin 1 x 450 mg Pirazinamid 1 x 1000 mg Ethambutol 1 x 500 mg
CHAPTER III
CASE ANALYSIS
Cirrhosis is defined histologically as a diffuse hepatic process characterized by
fibrosis and the conversion of normal liver architecture into structurally abnormal nodules.
The progression of liver injury to cirrhosis may occur over weeks to years.1
Many forms of liver injury are marked by fibrosis. Fibrosis is defined as an excess
deposition of the components of extracellular matrix (ie, collagens, glycoproteins,
proteoglycans) within the liver. This response to liver injury potentially is reversible. In
contrast, in most patients, cirrhosis is not a reversible process.2
III.1 Epidemiology2
Hepatic cirrhosis more often found within male to female with ratio 2,1 : 1, average
44 years old. highest incidence are from 13 – 88 years old with peak 40 – 55 years old.
This patient is 51 years old. It means that her age is included in the higest incidence of
hepatic chirrosis.
III.2 Hepatic Cirrhosis Classifications3
Based on the morphology of dividing Sherlock Cirrhosis of three types, namely:
1. Mikronodular
11
2. Makronodular
3. Mixture (which shows the picture of the micro-and makronodular)
In Functional Cirrhosis divided as follows:
1. Hepatic cirrhosis compensated
Often referred to as Latent liver cirrhosis. In this stage
visible symptoms are not real. This stage is usually found at the time screening
examination.
2. Hepatic cirrhosis Decompensated
Cirrhosis of the liver known as Active, and this stage usually have symptoms
clear, for example, ascites, edema and jaundice.
Status classification of cirrhosis based on Baveno IV :4
Stage 1 : no varices, no ascites
Stage 2 : varices, no ascites
Stage 3 : ascites with or without varices
Stage 4 : bleeding with or without ascites
In this case, the patients is diagnosed with hepatic cirrhosis decompensate since the
patient shows spider neavi, ascites, collateral vein, edema and jaundice. Based on cirrhosis
classification of Baveno IV, she is included in stage 3.
III.3 Etiology5
Causes of Cirrhosis Hepatic
1. Infectious Diseases
a. Capillariasis
b. Brucellosis
c. Echinococcosis
d. Schistosomiasis
e. Toxoplasmosis
f. Viral hepatitis hepatitis B, C, D
g. cytomegalovirus; Epstein-Barr virus
2. Inherited and Metabolic Disorders
a. Antitrypsin deficiency
12
b. Alagille’s syndrome
c. Biliary atresia
d. Familial intrahepatic cholestasis(FIC)
e. Fanconi’s syndrome
f. Galactosemia
g. Gaucher’s disease
h. Glycogen storage disease
i. Hemochromatosis
j. Hereditary fructose intolerance
k. Hereditary tyrosinemia
l. Wilson’s disease
3. Drugs and Toxins
a. Alcohol
b. Amioradone
c. Arsenicals
d. Oral contraceptives
e. Pyrrolidizine alkaloids and antineoplastic agents
4. Other Causes
a. Biliary obstruction (chronic)
b. Cystic fibrosis
c. Graft-versus-host disease
d. Jejunoileal bypass
e. Nonalcoholic fatty liver disease
f. Primary biliary cirrhosis
g. Primary sclerosing cholangitis
h. Sarcoidosis
5. Unknown Aetiology
The Etiology of hepatic cirrhosis in this patient is viral hepatitis B because the
result of HbsAg serologic test is positive and HCV is negative.
Besides, from the anamnesis we have known that the patient was suffered
“jaundice” 5 years ago and was hospitalized in RSMH, and her mother also ever got
13
“hematemesis” and yellowish eyes. From her statement we have thought that it’s possible
the patient ever got hepatitis. We can think that the viral maybe was transmitted from her
mother because her mother had ever shown the symtomps that lead to hepatitis, too. Her
deniel about consuming alcohol at least can eliminate the etiology of alcohol.
III.4 Signs and Symptoms6
The signs and symptoms of liver cirrhosis may be absent or non-specific at early
stages. Early non-specific symptoms include fatigue and itching. As scar tissue replaces
healthy tissue and liver function worsens, a variety of liver-related symptoms may
develop. Actually, the patient with hepatic chirrosis came to physician with complain of
fatigue, itching, edema/ascites, digestive tract bleeding,and jaundice.
III.5 Physical Examination7
Physical examination findings depend on the stage of the disease. In the early
stages, examination findings are normal. Physical examination specific for hepatic cirrosis
are :
Hepatomegaly
Hyperpigmentation
Splenomegaly
Jaundice
spider naevi,
palmar erythema,
ascites,
and peripheral edema
This patient came to hospital with complaint of the enlargement of abdominal
bulging, jaundice, fatigue. From physical examination, we can found spider naevi, ascites,
collateral vein, icteric and pripheral edema. Spleen and hepar is difficult to examined due
to massif ascites. All of the signs and symptoms can lead to diagnosis of cirrhosis hepatic.
The formation of ascites in cirrhosis depends on the presence of unfavorable
starling forces within the hepatic sinusoid. The increased sinusoidal pressure that develops
14
in portal hypertension increases the amount of fluid entering the space of Disse. When the
increased hepatic lymph production observed in portal hypertension exceeds the ability of
the cisterna chyli and thoracic duct to clear the lymph, fluid crosses into the liver
interstitium. Fluid may then extravasate across the liver capsule into the peritoneal cavity. 1
Therefore, we thought that this patient has had portal hypertension that was
showed by presence of ascites and collateral vein. The absence of melena or hematemesis,
means that there was no bleeding of gastroesophageal varices yet in this patient. But, we
should considered it in the therapy in order to prevent the bleeding.
III.6 Laboratory Findings
Laboratory Findings
Hepatic Cirrhosis is marked by laboratory findings abnormalities such as: 8
Elevation of SGOT and SGPT. If SGPT is normal, it doesn’t mean the diagnosis of
cirrhosis hepatic is eliminated. In viral hepatitis, the serum SGOT is usually
disproportionately elevated relative to SGPT, i.e , SGOT/SGPT ratio > 2. 5
Elevation of Alkaline phosphates.
Elevation of Bilirubin.
Elevation of globulin, reduction of albumin.
Elongated PT.
Reduction of Sodium.
Hematology abnormalities such as anemia, trombositopenia and leukopenia.
Laboratory findings show anemia (Hb: 5,2 g/dl, Hct : 18%, eritrosit:
2.140.000/mm3), trombositopenia (trombosit : 158.000 mm), elevated of total bilirubin,
direct bilirubin and indirect bilirubin, elevated SGOT (85u/l), normal SGPT (25u/l),
hypoalbuminemia, due to decrease function the liver. This laboratory finding can
strenghtened the diagnosis of cirrhosis hepatic.
Anemia in this patient was normochromic normocitic, it was showed by normal
MCV and decreased or normal MCHC.9 Based on the criteria, we diagnosed the patient
15
with anemia chronic disease. It means that the anemia was appeared since the chronic
disease that she had, in this case is cirrhosis hepatic.
The elevated of SGOT because of decrease function the liver, aventhough SGPT
was still normal. The ratio of SGOT/SGPT >2 is occured in viral hepatitis. 5 In this case,
the ratio SGOT/SGPT is 3,4. ( 85u/l / 25u/l = 3,4). So, it can strenghtened that the
etiology cirrhosis in this patient is from viral hepatitis.
The elevated of total bilirubin, direct bilirubin and indirect bilirubin was also
caused of decrease function the liver. The elevated of bilirubin has caused the urobilinogen
in urine increased, so that the patient had tea color urine.
The inverse of ratio albumin/globulin was also happened in this patient. It was
showed by decreased of albumin and elevated of globulin. The decreased of albumin
because of decrease function the liver has made hypoalbuminemia in this patient. At last,
the hypoalbuminemia has caused the ascites became increased and edema pretibial was
appeared.
The benzidine test has been also done, and the result is negative. It means that
both melena microscopic and macroscopic is not occured in this patient.
The ureum and creatinin were also elevated in this patient. Based on assessment of
Creatinin Clearence :
(140-age) body weight x 0,85 72 x creatinin serum
= (140-51) 55 x 0,85 = 36, 18 ml/minute72 x 1,6
The CCT in this patient is 36,18 ml/minute. It’s included early renal insufficiency
(GFR or CCT : 30-59 ml/minute), according to the K/DOQI CKD classification. 10
III.7 Diagnosis
Current diagnosis is hepatic cirrhosis decompensate that was built from anamnesis,
physical findings, laboratory findings and supporting examination (abdominal USG,
endoscopy,and liver biopsy). 5
16
This patient abdominal USG gave result: small size, uneven surface, parenchymal
rude, blunt edge, ascites (+), no spleenomegali. It can can strenghtened the diagnosis of
cirrhosis hepatic. Endoscope examination hasn’t been done, but it is needed to found
esophageal varices. Cirrhosis is best determined by examining a sample of liver tissue
under the microscope, a procedure which is called a liver biopsy. Liver biopsy is the gold
standard to diagnose hepatic cirrhosis and differentiate the stadium. The diagnosis is
precise when examination shows fibrosis and regeneration nodul inside hepatic cells. 5
Therefore liver biopsy examination is also planned for this patient.
III. 8 Treatments
Non-pharmacology: 11
1. Bed rest
It is shown to inhibit the neurohomural system (RAAS and SNS) activated
chronically in upright position in cirrhotic patients that impairs renal blood perfusion
and causes sodium retention. Bed rest reduces the plasma aldosterone level and
improves the response to diuretic therapy in cirrhotic patients. However, bed rest is
not recommended routinely as it is often unpractical and could cause decubitus ulcers
and muscle atrophy in malnourished cirrhotic patients.
2. Restrict dietary with balance nutrition: enough calories, protein 1gr/kgBB/day and
vitamin.
3. A balanced diet promotes regeneration of healthy liver cells.
Eating five or six small meals throughout the day should prevent the sick or bloated
feeling patients with cirrhosis often have after eating.
Pharmacology:
1. Diuretics
Diuretics should be considered the second line of therapy.
The diuretic of choice is spironolactone (50 to 200 mg per day). It blocks the
aldosterone receptor at the distal tubule. 1 It was began in initial dose , then the
dose can be increased gradually. After 4 days, if there is not improvement in
maximal dose, it can be combined with another drug such as furosemide. 3
17
Furosemide (Lasix) may be used as a solo agent or in combination with
spironolactone. The drug blocks sodium reuptake in the loop of Henle. Low
doses of furosemide (20 to 40 mg per day) may be added during the first few
days to increase natriuresis, especially when peripheral edema is present.
Furosemide should be used with caution because of the risk of excessive
diuresis, which may lead to renal failure of prerenal origin. The recommended
weight loss to prevent renal failure of prerenal origin is 300 to 500 g per day in
patients without peripheral edema and 800 to 1000 g per day in those with
peripheral edema. Patients infrequently need potassium repletion when
furosemide is dosed in combination with spironolactone. 1
In this case, we used spironolactone with initial dose 2 x 25mg. The dose has
been increased gradually until 3 x 100 mg. The improvement of ascites and edema
has been seen since 3 days after admission. It was proved by decrease of abdominal
circumference and body weight. From physical examination at 8 th August 2010, we
found the abdominal circumference was 88 cm and body weight was 55kg. In follow
up at 9th August 2010, the abdominal circumference was 88 cm and body weight
became 54 kg. At 10th August 2010, abdominal circumference was 86 cm and body
weight became 53 kg. Because of that, we maintened the dose in 3 x 100 mg without
combination with another drug.
To correct the hypoalbuminemia, we can use intravenous infusion of albumin
at 25 g twice per day, in addition to ongoing therapy with spironolactone. 1 Another
choice is albumin 20%, 35-70 drips/minute. 12 In this case, we used albumin 20% to
treat the hypoalbuminemia.
2. Propanolol (Beta blockers)
It may be prescribed to control cirrhosis-induced portal hypertension. Because
the diseased liver can no longer efficiently neutralize harmful substances,
medications must be given with caution. Interferon medicines may be used by
patients with chronic hepatitis B and hepatitis C to prevent post-hepatic cirrhosis. 11
This patient has been given propanolol tab 2 x 10 mg in order to control the
portal hypertension and prevent the bleeding as the complication of it.
18
3. Treatment of hyponatremia in cirrhosis
Treatment of hyponatremia in patients with cirrhosis includes sodium and
fluid restriction and continued treatments with spironolactone and loop diuretics.
However, care must be taken when administering diuretics as they can exacerbate
the reduction in tissue perfusion that occurs in cirrhosis, further impairing the ability
to excrete free water. Bolus infusions of 3% NaCl are reserved for patients with
profound hyponatremia and severe symptoms. 13
Fluid intake should be restricted (to approximately 1000 ml per day) only in
patients with dilutional hyponatremia, a condition characterized by a serum sodium
concentration of less than 130 mmol per liter in the presence of ascites, edema, or
both. Dilutional hyponatremia results from impaired renal excretion of free water
due to inappropriately high concentrations of antidiuretic hormone. 13
In this patient, we used IVFD NaCl 3% gtt x/m (micro) to improve the
hyponatremia. Then, to correct the hypokalemia we used KCl tab 3 x 600 mg. 12
Other drugs that we used to improve the sign and symptom in this patient are :
• Curcuma tab 2 x 200 mg to improve anorexia in this patient. 12
• Omeprazol tab 1 x 20 mg to cure the nausea and prevent vomit reflex, so the patient
could feel comfort and eat properly. 12
• Vit B1 B6 B12 (Neurodex) 3x1 tab as the supplement to her anemia beside of blood
transfussion.
III.9 Complications6
Since the liver performs many complex metabolic functions, there are many
complications that arise from cirrhosis. In addition, some complications arise more
commonly in certain diseases that cause cirrhosis (for example, osteoporosis occurs more
commonly in patients with liver diseases that predominantly affect the bile ducts). Below
is a list of some of the most common complications of liver disease.
1. spontaneous bacterial peritonitis.
2. Bleeding from esophageal or gastric (stomach) varices
3. hepatic encephalopathy
4. Liver Cancer (Hepatocellular Carcinoma.
19
In this patient, we haven’t found complication like above. So, we try to make the
best treatment in order to prevent the complications that can be occured in this patient.
III.10 Prognosis
Prognosis of patients with cirrhosis depending on the presence or absence of
complications of cirrhosis. Patient with cirrhosis compensated have a longer life
expectancy if they do not develop into cirrhosis decompensated. An estimated ten-year life
expectancy of patients with cirrhosis compensated approximately 47%. Conversely patient
with cirrhosis decompensated have life expectancy is only 16% within five years. these
patients leads to a poor prognosis. 2 Based on Child-Pugh score, the score employs five
clinical measures of liver disease. Each measure is scored 1-3, with 3 indicating most
severe derangement. 14
Measure 1 point 2 points 3 points units
Bilirubin (total) <34
(<2)
34-50
(2-3)
>50
(>3)
μmol/l
(mg/dl)
Serum albumin >3,5 2,8-3,5 <2,8 g/dl
INR <1.7 1.71-2.20 > 2.20 no unit
Ascites None Mild (can be controled easy) Severe no unit
Hepatic
encephalopathy
None Grade I-II (or suppressed
with medication)
Grade III-IV (or
refractory)
no unit
Different textbooks and publications use different measures. Some older reference works
substitute PT prolongation for INR.
Interpretation
Chronic liver disease is classified into Child-Pugh class A to C, employing the added score
from above. 14
Points Class One year survival Two year survival
5-6 A 100% 85%
7-9 B 81% 57%20
10-15 C 45% 35%
From the assessment has been done, the prognosis of this patient is included in 3 rd
category. It means that one year survival for this patient is approximately 45 % and two
year survival is 35%. It can be said dubia ad malam.
REFERENCES
1. Wolf, David, Cirrhosis, New York Medical College. New York. USA. 2010. Available from www.emedicine .com
2. Sulaiman, Ali. Akbar, Nurul. Lesmana L. Buku Ajar Ilmu Penyakit Hati. Jaya Abadi. Jakarta. 2007.
3. Maryani, Sri. Sirosis Hepatis. USU Digital Library. Sumatra Utara 2003. Available from library.usu.ac.id/download/fk/penydalam-srimaryani5.pdf
4. D’Amico G. Esophageal varices: from appearance to rupture; natural history and prognostic indicators. In: Groszmann RJ, Bosch J, editors. Portal hypertension in the 21st century. Dordrecht: Kluwer; 2004. p. 147–154.
5. Kasper, Dennis, et al. Harrison Principle Of Internal Medicine Sixteenth Edition.Mc. Graw-Hill. New York. USA 2005
6. Sanchez, William. Jayant, A. Talwalkar, Liver Cirrhosis. The American College of Gastroenterology, Bethesda, Available from www.acg.gi.org
7. Pyrsopoulos, Nikolaos, Primary Biliary Cirrhosis: Differential Diagnoses & Workup. University of Central Florida College of Medicine. USA 2010. Available from http://emedicine.medscape.com/article/171117.
8. Noer S. Sirosis Hati. Buku Ajar Ilmu Penyakit Dalam. Jilid I. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam. Edisi IV FKUI. 2006; 445-48.
9. Baldy CM. Gangguan Sel Darah Merah. In : Price SA, Wilson LM, editors. Patofisiologi Konsep Klinis Proses Penyakit. Ed 6. Jakarta: EGC; 2003.hlm.256-257.
21
10. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005; 67: 2089–100.
11. Pere Gines et al. Management of Cirrhosis and Ascites. The New England Journal of Medicine. Masschusetts Medical Society. 2004; 350: 1646-54
12. Bromilow, David, dkk. MIMS Indonesia. Vol 2. Number 1. Medi Media International Group. 2000.
13. Lindsay A. Profound hyponatremia in cirrhosis: a case report ,Case Western Reserve University, School of Medicine, 10900 Euclid Ave, Cleveland, OH 44106, USA Cases Journal 2010, 3:77
14. Child CG, Turcotte JG. Surgery and portal hypertension. In: The liver and portal hypertension. Edited by CG Child. Philadelphia: Saunders 1964:50-64.
RATIFICATION
The case report with the title :
A 51 Years Old Female Came to The Hospital with Chief Complaint
The Enlargement of Abdominal Bulging became Worse
since One Day before Admission.
By :
Much. Apriyanto, S.Ked (04061001008)Khori Pretika, S.Ked (04061001111)
has been accepted as one of the requirements in following the registrar of senior clinic
in Internal Medicine Department Medical Faculty of Sriwijaya University
22
Palembang, August 2010
Advisor :
Prof. Dr. H. Eddy Mart Salim, SpPD, K-AI
CONTENTS
COVER.....................................................................................................................i
RATIFICATION......................................................................................................ii
CONTENTS............................................................................................................iii
CHAPTER I INTRODUCTION..............................................................................1
CHAPTER II CASE REPORT................................................................................2
CHAPTER III CASE ANALYSIS.........................................................................12
REFERENCES.......................................................................................................22
23